Yongbo Pan
Nanjing, 210096, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Lactylation of PD-L1 by a lactyltransferase HAT1 dictates its protein stability and tumor immune evasion.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 27, 2026
FKBP9 enhances IGF2BP1-mediated m6A recognition to promote hepatocellular carcinoma progression.
Journal: JHEP reports : innovation in hepatology
Published: March 20, 2025
Posttranscriptional regulation of PD-1 by PRMT5/WDR77 complex shapes T cell effector function and antitumor immunity.
Journal: The Journal of clinical investigation
Published: January 21, 2025
METTL14 Enhances Antitumor Immunity through m6A-Dependent Loss of PD-1.
Journal: Cancer research
Published: January 06, 2025
P5CS represses tumor progression via inhibiting assembly of 48S pre-translation initiation complex.
Journal: Developmental cell
Published: December 17, 2024
m6A modification enhances the stability of CDC25A promotes tumorigenicity of esophagogastric junction adenocarcinoma via cell cycle.
Journal: International journal of biological sciences
Published: May 16, 2024
Epitranscriptic regulation of HRAS by N6-methyladenosine drives tumor progression.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 30, 2023
HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1.
Journal: Cell death & disease
Published: September 29, 2022
LCDR regulates the integrity of lysosomal membrane by hnRNP K-stabilized LAPTM5 transcript and promotes cell survival.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 02, 2021
DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma.
Journal: Cell death & disease
Published: September 20, 2021
Last Updated: 09/26/2026